ciprofloxacin has been researched along with dicloxacillin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baxter, R; Chapman, J; Drew, WL | 1 |
| Erlendsdóttir, H; Gottfredsson, M; Gudmundsson, A; Gudmundsson, S | 1 |
| Byron, MP; Carruth, WA; Hampton, AA; Sherertz, RJ; Solomon, DD | 1 |
| Burman, WJ; Cohn, DL; Reves, RR; Wilson, ML | 1 |
| Kong, CH; Lee, SW; Li, RC | 1 |
| Frimodt-Møller, N; Hertz, FB; Løbner-Olesen, A | 1 |
2 review(s) available for ciprofloxacin and dicloxacillin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Multifocal cellulitis and monoarticular arthritis as manifestations of Helicobacter cinaedi bacteremia.
Topics: Adult; AIDS-Related Opportunistic Infections; Arthritis, Infectious; Bacteremia; Cellulitis; Child, Preschool; Ciprofloxacin; Dicloxacillin; Doxycycline; Female; Follow-Up Studies; Helicobacter Infections; Humans; Male; Middle Aged | 1995 |
11 other study(ies) available for ciprofloxacin and dicloxacillin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of bactericidal activity of five antibiotics against Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Cephalexin; Ciprofloxacin; Clindamycin; Dicloxacillin; Female; Humans; Male; Middle Aged; Serum Bactericidal Test; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Different patterns of bacterial DNA synthesis during postantibiotic effect.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dicloxacillin; DNA, Bacterial; Escherichia coli; Gentamicins; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rifampin; Staphylococcus aureus; Tobramycin; Vancomycin | 1995 |
Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits.
Topics: Animals; Anti-Bacterial Agents; Catheterization; Catheters, Indwelling; Chlorhexidine; Ciprofloxacin; Clindamycin; Dicloxacillin; Fusidic Acid; Half-Life; Rabbits; Staphylococcal Infections | 1993 |
Correlation between bactericidal activity and postantibiotic effect for five antibiotics with different mechanisms of action.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dicloxacillin; Dose-Response Relationship, Drug; Escherichia coli; Linear Models; Microbial Sensitivity Tests; Models, Biological; Pseudomonas aeruginosa; Staphylococcus aureus; Tetracycline; Tobramycin; Trimethoprim | 1997 |
Antibiotic selection of Escherichia coli sequence type 131 in a mouse intestinal colonization model.
Topics: Amdinocillin; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Clindamycin; Dicloxacillin; Escherichia coli; Gram-Positive Bacteria; Meropenem; Mice; Penicillins; Thienamycins | 2014 |